Drug Trial Radar · NCT05848947
SIR-Spheres Study to Calculate the Radiation-Absorbed Dose of 99mTc-MAA
Last checked: Nov 20, 2026Latest source record: Jan 29, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
5
Actual
Start
Apr 25, 2023
Primary completion
Jul 5, 2023
Study completion Jul 5, 2023
Sponsor
- Lead sponsor
- Sirtex MedicalIndustry
- Sponsor type
- Industry
- Collaborators
- Bright Research Partners
- First posted
- May 8, 2023
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this interventional clinical trial is to evaluate the dose of radiation of Technetium-99m macroaggregated-albumin (99mTc-MAA) after an intra-arterial injection to the whole body and non-liver critical organs in patients who are undergoing evaluation for SIR-Spheres treatment for hepatocellular carcinoma.
Conditions
- Carcinoma
- Carcinoma, Hepatocellular
- Liver Neoplasm
Interventions
99mTc-Macro Albumin AggregateDrug
Technetium-99m macroaggregated-albumin consists of macroaggregated-albumin particles labeled with technetium-99m (99mTc), with a size between 10 and 90 microns in diameter. 99mTc is a gamma emitting radioactive isotope commonly used for diagnostic localization studies.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Absorbed Dose (Gy) for the Whole BodyTime frame: 18-24 hours
- Mean Absorbed Dose (Gy) for Critical Non-liver OrgansTime frame: 18-24 hours
- Mean Activity (Bq) for the Whole BodyTime frame: 18-24 hours
- Mean Activity (Bq) for Critical Non-liver OrgansTime frame: 18-24 hours
- Effective Dose (Gy) for the Whole BodyTime frame: 18-24 hours
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Inland Imaging
Spokane, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.